Aesthetic Medical International Holdings Group Limited (PAIYY)
OTCMKTS · Delayed Price · Currency is USD
0.1301
-0.1549 (-54.35%)
Jul 31, 2025, 3:47 PM EDT
Revance Therapeutics Market Cap
PAIYY has a market cap or net worth of $6.33 million as of August 1, 2025. Its market cap has decreased by -79.81% in one year.
Market Cap
6.33M
Enterprise Value
19.83M
Revenue
103.53M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.13
Market Cap Chart
Since October 25, 2019, PAIYY's market cap has decreased from 236.84M to 6.33M, a decrease of -97.33%. That is a compound annual growth rate of -46.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 6.33M | -56.77% |
| Dec 24, 2024 | 14.65M | -55.28% |
| Dec 29, 2023 | 32.76M | -17.28% |
| Dec 30, 2022 | 39.61M | -51.77% |
| Dec 31, 2021 | 82.12M | -34.01% |
| Dec 31, 2020 | 124.44M | -17.91% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.76B |
| Veradigm | 794.80M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 563.22M |
| Glass House Brands | 409.70M |
| Nika Pharmaceuticals | 366.89M |
| CytoDyn | 357.29M |
| Northwest Biotherapeutics | 351.67M |